Payment overview · 2025
General Payments
$18.12
1 reported records · 1 companies
Healthcare provider profile · identity verified
Subhakar Gummadi, MD
Allopathic & Osteopathic Physicians|Internal Medicine · BATON ROUGE, LA · NPI 1225014046
Verified facts
What the public records show
CMS Open Payments records show Subhakar Gummadi, MD received $18.12 in general payments during 2025 across 1 reported records.
Lundbeck LLC accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
A separate comparison found the same explicitly named product in public Medicare Part D data: Rexulti.
Lundbeck LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 71829 records involving 25812 distinct recipient NPIs. Public Medicare Part D data also shows 132 claims for Rexulti by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Lundbeck LLC | Unresolved — no canonical attribution shown | $18.12 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $18.12 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC | $18.12 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| REXULTI rexulti |
2025 | Rexulti | 2024 | 132 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Lundbeck LLC Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 71829 supporting records · 25812 recipient NPIs · example record 1251759986 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
132 | 18 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1608 | 150 |
| Levothyroxine Sodium | Levothyroxine Sodium | 912 | 92 |
| Amlodipine Besylate | Amlodipine Besylate | 879 | 84 |
| Eliquis | Apixaban | 834 | 64 |
| Furosemide | Furosemide | 815 | 92 |
| Gabapentin | Gabapentin | 742 | 83 |
| Potassium Chloride | Potassium Chloride | 728 | 77 |
| Tamsulosin Hcl | Tamsulosin Hcl | 687 | 65 |
| Trazodone Hcl | Trazodone Hcl | 622 | 58 |
| Pantoprazole Sodium | Pantoprazole Sodium | 611 | 70 |
| Donepezil Hcl | Donepezil Hcl | 588 | 57 |
| Metformin Hcl | Metformin Hcl | 534 | 57 |
| Metoprolol Succinate | Metoprolol Succinate | 528 | 58 |
| Mirtazapine | Mirtazapine | 479 | 55 |
| Memantine Hcl | Memantine Hcl | 474 | 53 |
| Quetiapine Fumarate | Quetiapine Fumarate | 444 | 52 |
| Clopidogrel | Clopidogrel Bisulfate | 365 | 40 |
| Lisinopril | Lisinopril | 360 | 37 |
| Sertraline Hcl | Sertraline Hcl | 343 | 31 |
| Escitalopram Oxalate | Escitalopram Oxalate | 338 | 48 |
| Divalproex Sodium | Divalproex Sodium | 332 | 37 |
| Metoprolol Tartrate | Metoprolol Tartrate | 322 | 48 |
| Carvedilol | Carvedilol | 311 | 32 |
| Fluoxetine Hcl | Fluoxetine Hcl | 286 | 34 |
| Levetiracetam | Levetiracetam | 271 | 27 |
| Duloxetine Hcl | Duloxetine Hcl | 260 | 31 |
| Famotidine | Famotidine | 256 | 31 |
| Omeprazole | Omeprazole | 236 | 25 |
| Olanzapine | Olanzapine | 233 | 28 |
| Losartan Potassium | Losartan Potassium | 225 | 39 |
| Risperidone | Risperidone | 202 | 30 |
| Hydralazine Hcl | Hydralazine Hcl | 188 | 22 |
| Finasteride | Finasteride | 176 | 15 |
| Entresto | Sacubitril/Valsartan | 174 | 11 |
| Hydrochlorothiazide | Hydrochlorothiazide | 166 | 18 |
| Simvastatin | Simvastatin | 161 | 16 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 157 | 43 |
| Montelukast Sodium | Montelukast Sodium | 157 | 17 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 155 | 13 |
| Benztropine Mesylate | Benztropine Mesylate | 154 | 16 |
| Citalopram Hbr | Citalopram Hydrobromide | 147 | 17 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 146 | 33 |
| Allopurinol | Allopurinol | 132 | 16 |
| Rexulti | Brexpiprazole | 132 | 18 |
| Buspirone Hcl | Buspirone Hcl | 114 | 12 |
| Fluticasone Propionate | Fluticasone Propionate | 111 | 37 |
| Tradjenta | Linagliptin | 106 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 102 | 13 |
| Pravastatin Sodium | Pravastatin Sodium | 101 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 100 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 100 | suppressed |
| Xarelto | Rivaroxaban | 99 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 94 | 23 |
| Jardiance | Empagliflozin | 87 | 15 |
| Ezetimibe | Ezetimibe | 86 | suppressed |
| Lactulose | Lactulose | 86 | 30 |
| Primidone | Primidone | 85 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 83 | suppressed |
| Latanoprost | Latanoprost | 81 | 20 |
| Novolin R Flexpen | Insulin Regular, Human | 81 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 80 | 25 |
| Divalproex Sodium Er | Divalproex Sodium | 80 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 78 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 78 | suppressed |
| Spironolactone | Spironolactone | 77 | 12 |
| Baclofen | Baclofen | 76 | suppressed |
| Linzess | Linaclotide | 76 | 15 |
| Ondansetron Hcl | Ondansetron Hcl | 76 | 24 |
| Novolog Flexpen | Insulin Aspart | 75 | 13 |
| Clonidine Hcl | Clonidine Hcl | 72 | 13 |
| Paroxetine Hcl | Paroxetine Hcl | 72 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 71 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 71 | 17 |
| Methocarbamol | Methocarbamol | 70 | 21 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 70 | 47 |
| Atenolol | Atenolol | 69 | suppressed |
| Bupropion Xl | Bupropion Hcl | 69 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 66 | 13 |
| Cephalexin | Cephalexin | 65 | 28 |
| Propranolol Hcl | Propranolol Hcl | 64 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 63 | suppressed |
| Gemtesa | Vibegron | 63 | suppressed |
| Glipizide | Glipizide | 63 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 61 | 31 |
| Midodrine Hcl | Midodrine Hcl | 60 | 11 |
| Bupropion Hcl Sr | Bupropion Hcl | 59 | suppressed |
| Trulicity | Dulaglutide | 59 | suppressed |
| Aripiprazole | Aripiprazole | 58 | 14 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 57 | suppressed |
| Meloxicam | Meloxicam | 57 | suppressed |
| Sucralfate | Sucralfate | 56 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 55 | suppressed |
| Januvia | Sitagliptin Phosphate | 54 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 54 | suppressed |
| Metolazone | Metolazone | 53 | suppressed |
| Myrbetriq | Mirabegron | 53 | suppressed |
| Haloperidol | Haloperidol | 52 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 51 | suppressed |
| Glipizide Er | Glipizide | 50 | suppressed |
| Carbamazepine | Carbamazepine | 49 | suppressed |
| Timolol Maleate | Timolol Maleate | 48 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 48 | 16 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 47 | 18 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 45 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 45 | suppressed |
| Ibuprofen | Ibuprofen | 44 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 43 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 43 | suppressed |
| Nifedipine Er | Nifedipine | 42 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 42 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 41 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 41 | suppressed |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 40 | 17 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 39 | 33 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 39 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 38 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 38 | suppressed |
| Ingrezza | Valbenazine Tosylate | 38 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 38 | suppressed |
| Amoxicillin | Amoxicillin | 37 | 13 |
| Benazepril Hcl | Benazepril Hcl | 37 | suppressed |
| Bumetanide | Bumetanide | 37 | suppressed |
| Fluconazole | Fluconazole | 37 | 26 |
| Dicyclomine Hcl | Dicyclomine Hcl | 36 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 36 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 36 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 35 | suppressed |
| Ondansetron Odt | Ondansetron | 35 | 19 |
| Valacyclovir | Valacyclovir Hcl | 35 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 34 | 31 |
| Invega Sustenna | Paliperidone Palmitate | 34 | suppressed |
| Lidocaine Hcl Viscous | Lidocaine Hcl | 34 | suppressed |
| Nystatin | Nystatin | 34 | 21 |
| Prednisone | Prednisone | 34 | 28 |
| Chlorthalidone | Chlorthalidone | 33 | suppressed |
| Colchicine | Colchicine | 33 | suppressed |
| Permethrin | Permethrin | 32 | 17 |
| Pregabalin | Pregabalin | 32 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 31 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 31 | suppressed |
| Digoxin | Digoxin | 31 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 31 | suppressed |
| Levofloxacin | Levofloxacin | 31 | 28 |
| Namzaric | Memantine Hcl/Donepezil Hcl | 31 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 30 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 30 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 29 | suppressed |
| Lumigan | Bimatoprost | 29 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 29 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 29 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 28 | suppressed |
| Ertapenem | Ertapenem Sodium | 28 | 18 |
| Metformin Hcl Er | Metformin Hcl | 28 | suppressed |
| Mitigare | Colchicine | 28 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 27 | suppressed |
| Telmisartan | Telmisartan | 27 | suppressed |
| Gemfibrozil | Gemfibrozil | 26 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 26 | suppressed |
| Novolin R | Insulin Regular, Human | 26 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 26 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 26 | suppressed |
| Valproic Acid | Valproic Acid | 26 | suppressed |
| Fenofibrate | Fenofibrate | 25 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 25 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 25 | suppressed |
| Celecoxib | Celecoxib | 24 | suppressed |
| Insulin Aspart | Insulin Aspart | 24 | suppressed |
| Novolog | Insulin Aspart | 24 | suppressed |
| Azithromycin | Azithromycin | 23 | 22 |
| Brimonidine Tartrate | Brimonidine Tartrate | 23 | suppressed |
| Glimepiride | Glimepiride | 23 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 23 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 23 | suppressed |
| Velphoro | Sucroferric Oxyhydroxide | 23 | suppressed |
| Isentress | Raltegravir Potassium | 22 | suppressed |
| Topiramate | Topiramate | 22 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 22 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 21 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 21 | suppressed |
| Ozempic | Semaglutide | 21 | suppressed |
| Cefdinir | Cefdinir | 20 | 18 |
| Insulin Aspart Flexpen | Insulin Aspart | 20 | suppressed |
| Ivermectin | Ivermectin | 20 | 12 |
| Meclizine Hcl | Meclizine Hcl | 20 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 19 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 19 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 19 | 17 |
| Polymyxin B Sul-Trimethoprim | Polymyxin B Sulf/Trimethoprim | 18 | 11 |
| Prednisolone Acetate | Prednisolone Acetate | 18 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 17 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 17 | suppressed |
| Scopolamine | Scopolamine | 17 | suppressed |
| Xifaxan | Rifaximin | 17 | suppressed |
| Clozapine | Clozapine | 16 | suppressed |
| Creon | Lipase/Protease/Amylase | 16 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 16 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 16 | suppressed |
| Valsartan | Valsartan | 16 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 15 | suppressed |
| Cilostazol | Cilostazol | 15 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 15 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 15 | suppressed |
| Sotalol | Sotalol Hcl | 15 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Levemir Flexpen | Insulin Detemir | 14 | suppressed |
| Rivastigmine | Rivastigmine | 14 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 14 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 14 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 14 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 14 | suppressed |
| Cyclosporine | Cyclosporine | 13 | suppressed |
| Fentanyl | Fentanyl | 13 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 13 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 13 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 13 | suppressed |
| Vascepa | Icosapent Ethyl | 13 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 13 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 12 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Mupirocin | Mupirocin | 12 | suppressed |
| Nitroglycerin | Nitroglycerin | 12 | suppressed |
| Restasis | Cyclosporine | 12 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 12 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 12 | suppressed |
| Entacapone | Entacapone | 11 | suppressed |
| Hydrocortisone | Hydrocortisone | 11 | suppressed |
| Simbrinza | Brinzolamide/Brimonidine Tart | 11 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 11 | suppressed |
| Verapamil Er | Verapamil Hcl | 11 | suppressed |
| Victoza 3-Pak | Liraglutide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $18.12 · 1 records | Lundbeck LLC | REXULTI | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Rexulti play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Lundbeck LLC?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error